**Core Concept**
In Acute Lymphoblastic Leukemia (ALL), a group of childhood cancers characterized by the proliferation of immature lymphocytes, several prognostic factors determine the outcome and guide treatment decisions. The presence of certain genetic and clinical features can significantly impact the disease's aggressiveness and response to therapy.

**Why the Correct Answer is Right**
The correct answer is associated with a poor prognosis in children with ALL due to its impact on the disease's biology and treatment response. The presence of **Wilm's Tumor Gene (WT1) expression** and **high levels of leukemic cell proliferation** are indicative of a more aggressive disease course. Furthermore, the **absence of the ETV6-RUNX1 fusion** and **presence of the MLL rearrangement** are also associated with a poorer prognosis in children with ALL.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately represent a recognized poor prognostic factor in children with ALL.
**Option B:** This option is incorrect because it is not associated with a poor prognosis in children with ALL.
**Option C:** This option is incorrect because it is actually a favorable prognostic factor in children with ALL.

**Clinical Pearl / High-Yield Fact**
Children with ALL who present with high leukocyte counts (>50,000/μL) and **central nervous system (CNS) involvement** have a significantly poorer prognosis and require more intensive treatment approaches.

**Correct Answer:** D.